DiagnaMed Brings AI To Brain Health — With Fabio Chianelli And Dr. John Kounios
Joining us today on the Daily Dive is that of DiagnaMed Holdings (CSE: DMED) Chairman Fabio Chianelli, and Dr. John
Read more
DiagnaMed Holdings
DiagnaMed Licenses Brain Health Tech From University Of Miami For AI Platform
DiagnaMed Holdings (CSE: DMED) is moving to enhance its brain health artificial intelligence platform known as CERVAI. The company has
Read more
DiagnaMed Focuses On Brain Health AI Platform Development
DiagnaMed Holdings (CSE: DMED) appears to be going all in on artificial intelligence. The drug development firm this morning revealed
Read more
DiagnaMed Looks To Obtain Approval For Brain Age Clinical Tool In Q4
DiagnaMed Holdings (CSE: DMED) is moving towards obtaining regulatory approval for its Brain Age clinical solution by the end of
Read more